Mitsubishi Tanabe Pharma Corporation · Osaka Japan
| 3-2-10, Dosho-Machi, Chuo-Ku | Phone: +81-6-6205-5085 |
| Osaka | Fax: +81-6-6205-5262 |
| 541-8505 | |
| Japan | 
Map This Company |
Mitsubishi Tanabe Pharma Corporation Rankings
Company Description
Japanese drug firm Mitsubishi Tanabe Pharma makes proprietary prescription pharmaceuticals in a number of therapeutic areas, including cardiovascular disease, diabetes, neuroscience, immunology, and oncology. In its home market, it sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. Its Benesis unit makes therapeutic plasma proteins such as albumin. The company markets and sells its products through in-house sales agents and distributors. Formerly Mitsubishi Pharma, the company merged with fellow Japanese drugmaker Tanabe Seiyaku and subsequently changed its name;
Mitsubishi Tanabe Pharma Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | March |
| Employees | 9,198 |
Executives
21 executives listed for Mitsubishi Tanabe Pharma Corporation's Osaka, Japan location.
| President, CEO, and Director | Michihiro Tsuchiya | |
|---|---|---|
| EVP and Director | Kunihiko Shimojuku |